Epysqli Drug Interactions
Currently displaying a list of 102 drugs known to interact with Epysqli (eculizumab).
- 46 major drug interactions
- 47 moderate drug interactions
- 9 minor drug interactions
Medications known to interact with Epysqli
Note: Showing generic names only.
- abrocitinib
- adalimumab
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- anakinra
- anifrolumab
- ashwaganda
- atezolizumab
- avelumab
- azathioprine
- baricitinib
- bcg
- bcg vaccine
- belimumab
- bifidobacterium infantis
- bifidobacterium longum
- brewer's yeast
- canakinumab
- cat's claw
- cemiplimab
- certolizumab
- chikungunya vaccine, live (cvx 317)
- cholera vaccine, live
- cladribine
- cosibelimab
- crovalimab
- dengue vaccine
- denosumab
- deucravacitinib
- dimethyl fumarate
- diroximel fumarate
- dostarlimab
- durvalumab
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- infliximab
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, live
- ipilimumab
- iptacopan
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- loncastuximab tesirine
- retifanlimab
- rilonacept
- ritlecitinib
- rituximab
- roflumilast
- rotavirus vaccine
- rozanolixizumab
- rubella virus vaccine
- ruxolitinib topical
- talimogene laherparepvec
- teriflunomide
- tislelizumab
- tofacitinib
- toripalimab
- tremelimumab
- typhoid vaccine, live
Epysqli disease interactions
There are 5 disease interactions with Epysqli (eculizumab) which include:
Report options
More about Epysqli (eculizumab)
- Epysqli consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Fabhalta
Fabhalta is used to treat paroxysmal nocturnal hemoglobinuria (PNH), primary immunoglobulin A ...
Empaveli
Empaveli (pegcetacoplan) is an immunosuppressant that is given by subcutaneous (under the skin) ...
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
PiaSky
PiaSky (crovalimab-akkz) may be used to treat paroxysmal nocturnal hemoglobinuria (PNH) in adults ...
Bkemv
Bkemv (eculizumab-aeeb) is an interchangeable biosimilar to Soliris which may be used to treat ...
Danicopan
Danicopan systemic is used for paroxysmal nocturnal hemoglobinuria
Iptacopan
Iptacopan is an oral capsule used to treat paroxysmal nocturnal hemoglobinuria (PNH) or to reduce ...
Pegcetacoplan
Pegcetacoplan (brand name Empaveli) is a twice-weekly, injectable medicine that may be used to ...
Ravulizumab
Ravulizumab-cwvz is used to treat myasthenia gravis (gMG), hemolytic uremic syndrome (aHUS) ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.